Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients.

Background: Primary goal of this randomized, double-blind, placebo-controlled crossover study of Renadyl in end-stage renal disease patients was to assess the safety and efficacy of Renadyl measured through improvement in quality of life or reduction in levels of known uremic toxins. Secondary goal...

Full description

Bibliographic Details

Published in:	BioMed Research International Vol. 2014; pp. 568571 - 568572
Main Authors:	Natarajan, Ranganathan, Pechenyak, Bohdan, Vyas, Usha, Ranganathan, Pari, Weinberg, Alan, Liang, Peter, Mallappallil, Mary C, Norin, Allen J, Friedman, Eli A, Saggi, Subodh J
Format:	Journal Article
Published:	Wiley-Blackwell 2014
Online Access:	View this record in EBSCOhost